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Abstract
The dendritic tree is a key determinant of neuronal information processing. In the motor system, the dendritic tree
of spinal cord neurons undergoes dramatic remodeling in an activity-dependent manner during early postnatal
life. This leads to the proper segmental spinal cord connectivity that subserves normal locomotor behavior. One
molecular system driving the establishment of dendrite architecture of mammalian motor neurons relies on AMPA
receptors (AMPA-Rs) assembled with the GluA1 subunit, and this occurs in an NMDA receptor (NMDA-R)-
independent manner. The dendrite growth promoting activity of GluA1-containing AMPA-Rs depends on its
intracellular binding partner, SAP97, and SAP97’s PDZ3 domain. We show here that cysteine-rich interactor of
PDZ3 (CRIPT) is a bona fide SAP97 PDZ3-domain binding partner, localizes to synapses with GluA1 and SAP97
along the dendritic tree, and is a determinant of the dendritic growth of mammalian spinal cord neurons. We
further show that CRIPT has a well-conserved ortholog in the nematode, Caenorhabditis elegans, and animals
lacking CRIPT display decreased dendrite branching of the well-studied PVD neuron in vivo. The lack of CRIPT
leads to a selective defect in touch perception, and this is rescued by expression of wild-type (WT) human CRIPT
(hCRIPT) in the nervous system. This work brings new light into the molecular machinery that drives dendritic
growth during development and may prove relevant to the promotion of nervous system plasticity following insult.
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Significance Statement
Proper dendritic growth is a critical step in the development of neuronal connectivity that underlies proper
neuronal communication. Much is known about how NMDA receptors (NMDA-Rs) drive neuronal develop-
ment and plasticity, but less is known about how AMPA receptors (AMPA-Rs) contribute in an independent
manner. While SAP97 plays a critical role in this process, the molecular mechanisms and binding partners
that subserve these effects are under active exploration. Here, we show that the cysteine-rich interactor of
PDZ3 (CRIPT) is a bona fide binding partner of SAP97 in biochemical assays and resides in dendrites in the
vicinity of putative AMPAergic synapses. In knockdown experiments, we find that CRIPT is essential for
SAP97-dependent dendrite growth in vitro. We extend these studies to an in vivo model and show that
CRIPT is also essential for dendrite growth and mechanosensory function in Caenorhabditis elegans. This
work links AMPA-Rs, MAGUKs, and CRIPT to essential neuronal cell biology and C. elegans behavior.
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Introduction
Activity-dependent development occurs throughout the
neuroaxis, including the spinal cord, during early postna-
tal life (Inglis et al., 2002; Haas et al., 2006; Ni and
Martin-Caraballo, 2010). During early postnatal life, motor
neurons express a distinct set of excitatory glutamate
receptor subunits and this coincides with the period of
extensive dendrite growth and remodeling (Jakowec
et al., 1995a,b; Stegenga and Kalb, 2001; Jeong et al.,
2006). These alterations in dendritic architecture are con-
fined to a critical period and this is subserved by the
unique repertoire of glutamate receptors expressed by
young spinal cord neurons (Jakowec et al., 1995a,b; Inglis
et al., 2002; Jeong et al., 2006).
Activity-dependent growth of the motor neuron den-
dritic tree is driven by two parallel glutamate receptor
mediated processes: (1) an NMDA receptor (NMDA-R)-
mediated mechanism (Kalb, 1994) and (2) an NMDA-R-
independent mechanism (Zhang et al., 2008). This later
process depends on the activation of AMPA receptors
(AMPA-Rs) assembled with the GluA1 subunit and its
intracellular binding partner, synapse associated protein
of 97 kDa (SAP97; Sans et al., 2001; Zhang et al., 2008;
Zhou et al., 2008). Animals lacking the GluA1 subunit or
SAP97 in motor neurons have a stunted dendritic tree and
suffer locomotor impairments that persist throughout life
(Zhang et al., 2008; Zhou et al., 2008). All of the dendrite
promoting actions of GluA1 are mediated by SAP97 (Zhou
et al., 2008). Trafficking of SAP97 to the cell surface is
dependent on the interaction with GluA1, but GluA1 traf-
fics to the cell surface independent of its interaction with
SAP97 (Kim et al., 2005; Zhang et al., 2008). SAP97 is a
postsynaptic density (PSD) scaffolding protein with sev-
eral protein-protein interacting domains organized into
the following structure: NH2 -L27-PDZ1-PDZ2-PDZ3-
SH3-U5-GUK-COOH. Recent work indicates that the
binding of ligand(s) to the PDZ3 domain of SAP97 is
required for SAP97 to promote dendrite growth (Jablonski
and Kalb, 2013; Zhang et al., 2015).
To understand the molecular mechanism by which
GluA1 and SAP97 promote activity-dependent dendrite
growth, we asked: (1) what proteins bind to the PDZ3
domain of SAP97? and (2) what role do such proteins play
in dendritogenesis? Here, we focus on cysteine-rich in-
teractor of PDZ3 (CRIPT), a 12-kDa protein that localizes
to excitatory synapses and links proteins such as PSD
protein of molecular weight 95 kDa (PSD95) to microtu-
bules (Niethammer et al., 1998; Passafaro et al., 1999).
Because PSD95 and SAP97 have a similar domain struc-
ture and can functionally complement one another in
certain assays (Schlüter et al., 2006; Howard et al., 2010),
we asked whether CRIPT was a SAP97 PDZ3 ligand and
whether it could promote dendrite growth.
Materials and Methods
Antibodies
The following antibodies were used in biochemical
assays: immunoprecipitation of SAP97 (Thermo Fisher
Scientific, catalog #PA1-741), immunoblotting and immu-
noprecipitation of CRIPT (Protein Tech Group, catalog
#11211-1-AP), immunoprecipitation and immunoblotting
of HA-tag (BioLegend, 16B11, catalog #901512), immu-
noblotting of SAP97 (NeuroMab/Antibodies, catalog #73-
030), immunoprecipitation and immunoblotting of the
myc-tag (Cell Signaling Technology, 9B11 catalog #2276),
immunoblotting GluA1 (NeuroMab/Antibodies, catalog
#75-327), immunoblotting GluA2 (NeuroMab/Antibodies,
catalog #75-002), immunoblotting GluA4 (Cell Signaling
Technology, catalog #8070), immunoblotting NR1 (BD
PharMingen, catalog #556308), immunoblotting NR2A
(Alomone Labs, catalog #AGC002), immunoblotting
NR2B (Alomone Labs, catalog #AGC003), and immuno-
blotting actin [Cell Signaling Technology, catalog #3700
(mouse) or Sigma-Aldrich, catalog #A2066 (rabbit)]. The
adenomatous polyposis coli (APC) antibody used was
described previously (Midgley et al., 1997). The following
antibodies were used for immunocytochemistry: extracel-
lular epitopes of GluA1 (Alomone Labs, catalog
#AGC004), HA-tag [BioLegend, 16B11, catalog #901512
(mouse)], HA-tag [Santa Cruz Biotechnology, Y-11 (rab-
bit), catalog #SC-805], and synaptophysin (Sigma-
Aldrich, catalog #SAB4502906). Secondary antibodies
used included for immunocytochemistry: Alexa Fluor 633
or 568 Goat Anti-Mouse IgG (H  L; Invitrogen) and Alexa
Fluor 633 or 568 Goat Anti-Rabbit IgG (H  L; Invitrogen).
When primary antibody was omitted (or preimmune serum
was used), staining with these secondary antibodies
yielded no fluorescent signal, thus confirming the speci-
ficity of immunocytochemical signal. Secondary antibod-
ies for Western blottings (IR DYE) comes from Li-COR.
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Mixed spinal cultures
Rat mixed spinal cord neuron cultures were prepared
as previously described (Jeong et al., 2006; Zhang et al.,
2015). They were maintained in glia-conditioned medium
supplemented with trophic factors (Alomone Labs at a
concentration of 1.0 ng/ml): human neurotrophin-3, hu-
man neurotrophin-4, human brain-derived neurotrophic
factor, human cardiotrophin-1, human glial-derived neu-
rotrophic factor, and rat ciliary neurotrophic factor. One
half of the medium was replaced three times per week.
microRNA (miRNA) RNAi design and herpes simplex
virus (HSV) infection
miRNA was constructed by annealing two oligomers of
21 base pairs homologous to the CRIPT sequence to-
gether and adding BspE1 and FseI restriction sites to the
5’ and 3’ ends, respectively. Annealed oligomers were
subsequently cloned into the p1006 HSV vector using
the BspEI and FseI restriction sites. miRNA was designed
against the rat CRIPT sequence corresponding to the
ORF: 5’-CTCCACTTGCAGAATTT-3’. We generated an
RNAi-resistant CRIPT cDNA containing three silent muta-
tions in the miRNA target sequence of CRIPT by using the
QuikChange Site-Directed Mutagenesis kit using manu-
facturer’s protocol (Agilent). The miRNA target sequence
was mutated to: 5’-CTCTACCTGTAGAATTT-3’. Mutated
nucleotides are underlined. The p1006 vector was sub-
sequently used for HSV production as previously reported
(Neve et al., 1997) . The titer of virus used in these
experiments was 3–5  107 pfu/ml.
Heterologous cells and transfection
For all experiment except those involving APC, HEK293
cells were maintained in 5% CO2 at 37°C in DMEM (In-
vitrogen) supplemented with 10% fetal bovine serum
(FBS; Sigma), 1% penicillin/streptomycin (Pen/Strep;
Sigma). Cells were transfected (Lipofectamine 2000; In-
vitrogen) per manufacturer’s protocol when they were
75% confluent and were maintained in DMEM with 10%
FBS until lysed 48 h after transfection.
For experiments involving APC, HEK293 cells were
maintained at 37°C in 5% CO2 in DMEM (Life Technolo-
gies), supplemented with 10% FBS (GE Health Care Life
Sciences), 1% Pen/Strep (Life Technologies), and nones-
sential amino acids (1:100; Life Technologies). Cells were
transfected using FuGENE 6 (Promega), according to the
manufacturer’s instructions.
Immunoprecipitation and Western blotting
For immunoprecipitation experiments not involving
APC, lysates were made in 1% NP-40 lysis buffer (25 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40,
5% glycerol; 150 l per 60-mm dish) supplemented with
fresh protease and phosphtase inhibitor cocktail (Sigma).
After two washes in ice-cold 1 PBS, cells were lysed in
lysis buffer, sonicated (20% strength, 10 s), and centri-
fuged at 13,000  g for 10 min (4°C) to remove cellular
debris. Five percent of the lysate was saved for input, and
the remaining lysate was used for immunoprecipitation.
For immunoprecipitation, DynaBeads Protein G (Invitro-
gen) were precleared in PBS/1% Tween and were bound
to the antibodies (4 g of antibody; 30 min at room
temperature, RT). Lysate was added, incubated for 1 h at
RT, and the lysate and bead mixture was washed three
times in lysis buffer. Proteins were then boiled in 1% BME
and 1 SDS loading buffer (40 l total). Proteins were
immunoblotted following standard Western blotting tech-
nique using 4-12% Bis-Tris gels (Invitrogen) in MES-SDS
running buffer (Invitrogen). Bio-Rad SDS-PAGE standards
Low Range (catalog #161-0305) molecular weight mark-
ers were used. Gels were transferred onto nitrocellulose
(Bio-Rad) at 100V for 1 h at 4°C and blocked in 5% milk in
TBST buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl,
0.1% Tween 20). Primary antibodies were incubated in
blocking buffer as indicated overnight at 4°C. Secondary
anti-rabbit and anti-mouse Alexa Fluor 800/680-conju-
gated antibodies (Life Technologies) were diluted
1:10,000 in 5% milk in TBST buffer and binding was
detected using the Odyssey system (LiCor) Infrared Im-
aging System without saturating the protein bands. The
intensity values were normalized against the actin loading
control. Quantitative data were the average of no fewer
than three separate and independent experiments.
For immunoprecipitation experiments involving APC,
lysates were made using MEBC lysis buffer (50 mM Tris,
pH 7.5, 100 mM NaCl, 5 mM Na-EDTA, 5 mM Na-EGTA,
40 mM -glycerophosphate, and 0.5% NP-40) containing
a cocktail of protease inhibitors: leupeptin, pepstatin A,
chymostatin (each 10 g/ml), 1 mM NaVO4, and 10 mM
NaF. Cells were scraped and the mixture was spun at
14,000 rpm for 20 min at 4°C. Supernatants were re-
moved and immediately frozen using liquid nitrogen. To
measure the binding of endogenous APC to either wild-
type (WT) or mutant SAP97, 10 g of polyclonal anti-
SAP97 antibody (Fisher Scientific) was prebound to 100
l of 50% protein-A-Sepharose bead slurry (Sigma) by
gently agitating the mixture at 4°C for 16 h. After washing
the beads twice with MEBC, 0.5 mg of lysate from cells
transfected with WT or mutant SAP97 was added and
gently mixed for 16 h at 4°C. The beads were washed
three times with cold MEBC buffer before they were re-
suspended in 20 l SDS-PAGE loading buffer and heated
to 70°C. Samples (without the beads) were subjected to
SDS-PAGE using 4-12% gels (Life Technologies) in
MOPS-SDS running buffer (Life Technologies). Proteins
were transferred to GE Healthcare Protran nitrocellulose
membrane (0.1 m; GE Health Care Life Sciences). Blots
were probed with crude serum from rabbits immunized
with N-terminal portion of APC (Midgley et al., 1997)
diluted at a concentration of 1:1000 in blocking solution
(Tris-buffered saline, 5% nonfat milk, 1% goat serum, and
0.02% Triton X-100) and an anti-SAP97 antibody (Fisher
Scientific) diluted 1:1000. Secondary anti-rabbit and anti-
mouse Alexa Fluor 800/680-conjugated antibodies (Life
Technologies) were diluted 1:10,000 and binding was
detected with Odyssey (LiCor).
Surface plasmon resonance (SPR) sample
preparation
The PDZ3 domain of SAP97 was amplified by PCR and
the PCR product was ligated into the pGEX vector (GE)
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and transformed into BL21 strain. Correctness of the
construct was confirmed by sequencing. GST-PDZ3 fu-
sion protein expression was induced with isopropyl-1-
thio--D-galactopyranoside (IPTG) for 3 h. The bacteria
were harvested by centrifugation, resuspended in ice-
cold lysis buffer (50 mM Tris, 50 mM NaCl, 5 mM EDTA, 1
g/ml leupeptin, 1 g/ml pepstatin, 0.15 mM PMSF, and
1 mM 2-mercaptoethanol), and lysed by sonication on ice.
The bacterial lysates were cleared by centrifugation, and
supernatant was collected and incubated with glutathione
Sepharose 4B matrix. After extensive washes with lysis
buffer, glutathione Sepharose 4B resin was incubated
with freshly made 10 mM glutathione buffer (50 mM Tris
and 10 mM reduced glutathione, pH 8.0) to elute the GST
fusion protein. Purified GST-PDZ3 fusion protein was fur-
ther dialyzed to remove glutathione before plasmon res-
onance studies.
SPR measurements and affinity analysis of
sensorgrams
Association and dissociations reactions of peptides
CHRK1 (C-terminal amino acids of CRIPT) or CHRK2
(C-terminal amino acids of CRIPT V101A; as analytes) and
recombinant GST fusion protein GST-PDZ3 and GST (as
ligands) were performed using a Biacore3000 instrument.
Anti-GST antibody was immobilized on flow cell 3 and 4
according to the manufacturer’s instructions. GST and
GST-PDZ3 were then captured on flow cell 3 and flow cell
4 separately, where GST served for on-line reference
subtraction (values shown in data subtract any signal from
this negative control). Both the analytes and the ligands
were dissolved in the HBS running buffer (0.01 M HEPES,
0.15 M NaCl, 3 mM EDTA, and 0.005% v/v Surfactant
P20), and their concentrations were determined at UV 280
nm using extinction coefficients calculated from the
amino acid composition. The ligands were bound as den-
sities between 1200 and 1700 RU. The analytes of CHRK1
and CHRK2 in 45 l volume each with various concen-
trations (62.5 nM, 250 nM, 4 M, 8 M, 10.24 M, and
12.8 M) were injected over both GST and GST-PDZ3
surfaces at flow rate of 30 l/min. Dissociation time was
monitored for 3 min. A 40-s pulse of glycine-HCl, pH 2.2,
was applied to regenerate the GST surface. For GST-
PDZ3 surface regeneration, an additional 40-s pulse of
glycine-HCl was applied. Analysis of steady-state affinity
was performed using BIAevaluation software selecting
reference-subtracted curves with a 1:1 interaction model.
Affinity constant Kd was derived from Req versus C (re-
sponse unit at equilibrium vs peptide concentration) plot
with the steady-state affinity model fit. Data for GST
capture was subtracted from GST-PDZ3 values.
Neuronal transfection and neuron tracings
At 5 d in vitro (DIV), mixed spinal cultures were trans-
fected (Lipofectamine 2000; Invitrogen) with the overex-
pression plasmid or miRNA being tested in a 3:1 ratio with
GFP to ensure all GFP-positive cells also expressed the
desired construct. Five days after transfection, cells were
fixed in 4% paraformaldehyde and immunostained with
rabbit anti GFP antibody and secondary antibody. After
immunostaining, the coverslip with the cells was mounted
on the slide and viewed using fluorescent microscopy.
Neuronal tracings were performed with the Neurolucida
program (MicroBrightField) and analyzed with the Neuro-
explorer program (MicroBrightField). As previously de-
scribed (Zhang et al., 2008), the minimum inclusion
criteria for this study were: dendrites radially distributed
(180°) and no more than one primary dendrite is trun-
cated (less than three times the cell body diameter). In
addition, only processes 4 m were included in our
analysis since this distinguishes true branches from den-
dritic filopodia (Zhang et al., 2015). Quantitative descrip-
tors of the dendrites were as follows (Zhang et al., 2015):
1° dendrites: the number of primary dendrites leaving the
cell body; branches, #: the number of dendritic bifurca-
tions; length: sum of the linear length of all dendrites
from a single cell; average dendrite: the sum of the lengths
of all dendritic shafts from a single neuron divided by the
number of primary dendrites; and longest dendrite: the
length of the longest dendrite from the cell body to the
most distal tip. Spinal cord cultures were created over a
six-year period for these experiments and all the anatomic
drawings were performed by a single operator (L. Zhang)
blinded to experimental group. All drawings of neurons
within a specific experiment (three groups in Fig. 5, 6)
were done contemporaneously. Since specific experi-
ments were performed over 6 years, absolute values ob-
tained for one specific experiment cannot be directly
compared with the absolute values obtained for a second
specific experiment. Sources of variation include differ-
ences in batches of serum, Dams from different venders,
etc.
Immunocytochemical localization of CRIPT in mixed
spinal cord cultures
We found none of the commercially available antibodies
to CRIPT or SAP97 were suitable for immunocytochemi-
cal studies (e.g., Abcam; ProteinTech Group; Santa Cruz
Biotechnology, NeuroMab). We devised an alternative
strategy for visualizing CRIPT in neurons. We cotrans-
fected neurons with a miRNA designed to knockdown
endogenous CRIPT alongside an RNAi-resistant version
of WT CRIPT containing a hemagglutinin (HA) tag on the
amino terminus. When these plasmids were cotransfected
with a GFP reporter and stained for HA, we visualized
punctate HA immunoreactivity in the cell body and den-
drites of transfected neurons. The molar ratio of the trans-
fected plasmids (e.g., GFP:CRIPTmiRNA:RNAi resistant
HA-CRIPT was 1:5:2) to ensure that HA staining was
restricted to neurons with a high likelihood of concomitant
knockdown of endogenous CRIPT. Both mouse anti-HA
(BioLegend) and rabbit anti-HA (Santa Cruz Biotechnology)
worked well in this application. In one set of experiments, we
used a mammalian expression vector engineered to express
GFP-SAP97 in localization studies.
Membrane protein preparations
Cells were washed twice using ice-cold PBS and sus-
pended in hypotonic lysis buffer (10 mM KCl, 1.5 mM
MgCl2, and 10 mM Tris-Cl, pH 7.4, and 1.5 ml/60 mm
plate). After incubation on ice for 10 min, cell lysis was
finalized using a homogenizer (Dounce). The cell lysate
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was centrifuged at 2000  g for 2 min (4°C) to remove
nuclei and cellular debris and the supernatant was cen-
trifuged a second time at 100,000 g for 30 min at 4°C to
pellet cell membranes. The supernatant was saved as the
“cytoplasmic” fraction and the pellet (“membrane” frac-
tion) was resuspended in RIPA buffer (50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40,
and 1% sodium deoxycholate) supplemented fresh with
protease and phosphatase inhibitor cocktail (Sigma). Ly-
sates were boiled for 5 min in 1% BME (Bio-Rad) and 1
SDS-loading buffer before standard Western blotting
technique as described earlier using 4-12% Bis-Tris gels
(Invitrogen) in MES-SDS buffer (Invitrogen).
Yeast-two-hybrid (Y2H)
The PDZ3 domain of SAP97 flanked by five amino acids
on the N and C termini was amplified by PCR and cloned
into the yeast bait phagemid pBD-GAL4. Full-length (FL)
CRIPT was engineered into the yeast prey phagemid
pAD-UAS. YRG-2 yeasts were transformed (Clontech)
according to the manufacturer’s instructions with pha-
gemids or appropriate empty vector controls and grown
under restrictive conditions (SD media lacking leucine,
tryptophan, and/or histidine) and single colonies were
subsequently streaked onto restrictive plates. The plas-
mid, pGBT9, was used as a positive control.
CRIPT and SAP97 structural modeling
The SAP97 PDZ3 model was built in SWISS-MODEL
on-line server (http://swissmodel.expasy.org/). PSD95
PDZ3/CRIPT (PDB id:1BE9) was selected as the template
in the modeling process. For the SAP97/PDZ3/CRIPT
complex, CRIPT peptide was modeled from PSD95
PDZ3/CRIPT complex (PDB id:1BE9). Then, both the
complex structure was further adjusted manually to take
the N-terminal upstream residues of CRIPT into account.
Finally, the structure model was submitted to YASARA
Energy Minimization server (http://www.yasara.org/mini-
mizationserver.htm) to achieve the final SAP97/CRIPT
complex model.
Caenorhabditis elegans maintenance
All C. elegans strains were maintained using standard
methodology (Brenner, 1974). Animals were maintained at
20°C on nematode growth medium (NGM) agar plates
with live OP50 bacteria. A worm strain containing a dele-
tion within the C. elegans ortholog of CRIPT, tm430, was
obtained from National BioResource Project in Japan and
backcrossed three generations to ancestral N2 before
being crossed into the PPVD::GFP line. We also used the
mec-4 (u253) and mec-3 (e1338) strains, which were ob-
tained from the Caenorhabditis Genetics Center (CGC).
The mec-4 (u253) strain was backcrossed three genera-
tions to ancestral N2 before being analyzed and crossed
into the tm430 strain.
C. elegans rescue cloning and lines
Human CRIPT (hCRIPT) cDNA was amplified using
PCR. Gateway cloning (Invitrogen) was employed and the
BP reaction was used to construct the pDonR221-
hCRIPT (pEntry::hCRIPT) construct. The LR reaction was
then performed using the following constructs for the 1st,
2nd, and 3rd positions, respectively: unc-119 promoter,
pEntry::hCRIPT, and the unc-54 3’UTR. The LR reaction
was performed to insert this cassette into the pCFJ150
destination plasmid for C. elegans expression. Sanger
sequencing was used to confirm the correctness of the
final construct, Punc-119::hCRIPT::unc-54 3’UTR (Pneuron::
hCRIPT) enabling the expression of hCRIPT in the C.
elegans nervous system. To create transgenic extrachro-
masomal arrays, Pneuron::hCRIPT was injected into the
gonads of the indicated strains (at 1 d after the fourth
larval stage, L4) at a final concentration of 50 ng/l along
with a coinjection marker, pCFJ150 (Pmyo-2::mCherry) at a
final concentration of 5 ng/l. The final DNA concentration
of the injection mix was 100 ng/l; a sonicated LacZ
plasmid was used to arrive at the proper final DNA con-
centration as needed. At least three independent trans-
genic lines were created for each final strain, and all were
tested in corresponding assays.
C. elegans imaging
All lines were synchronized before visualizing GFP-
labeled PVD neurons. Briefly, young adult (1 d after L4)
hermaphrodites were allowed to lay eggs for 4-6 h. At the
L4 stage, noted by the presence of a clear vulva, animals
were moved to a separate plate and imaged one day later.
Animals were immobilized using levamisole (10 mM;
Sigma) on fresh 4% agar pads and imaged using confocal
microscopy. Z-stacks were obtained and merged, and
was analyzed by manually counting the number of den-
drites present on the PVD neuron dendritic tree (Smith
et al., 2010, 2013) from the cell body to the posterior end
of the animal. The number of primary, secondary, and
tertiary dendrites was determined as previously described
(Liu and Shen, 2011). The analyst was blind to experimen-
tal group during image acquisition and analysis.
C. elegans touch assay
In the touch assay, the midsection of the body near the
vulva was gently prodded with a platinum wire, as previ-
ously described (Way and Chalfie, 1989). A positive re-
sponse was scored as movements of at least one body
length in response to the touch stimulus, although the
speed of the animal can vary in different mutant back-
grounds.
Statistics
Statistical analysis was performed using GraphPad
Prism version 6.00 for Windows, GraphPad Software.
Unpaired t test was used for all two-group comparisons.
For data more than three groups, a one-way ANOVA with
Dunnett’s multiple comparisons test was used. For anal-
ysis of the neuronal tracings, a Shapiro–Wilk test was run
to test normality of the data (SPSS). If the data were
normally distributed, the data were analyzed with one-
way ANOVA. Post hoc analysis was performed with
Tukey’s test. If the data did not distribute normally, a
nonparametric Kruskal-Wallis H test (e.g., one-way
ANOVA on ranks) was used to analyze data. Post hoc
analysis was performed with Dunnett’s test. The threshold
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for significance was set at p  0.05 for all tests. Data are
presented as mean  SEM.
Results
CRIPT interacts with SAP97’s PDZ3 domain
Recent work has revealed that the third PDZ domain of
SAP97 is critical for the prodendrite-growth activity of
SAP97 (Zhang et al., 2015). Identification of the endoge-
nous SAP97 PDZ3 domain ligand(s) responsible for this
biological activity is problematic because the list of can-
didates contains 90 potential binding partners (see “in-
teractions” at http://www.ncbi.nlm.nih.gov/gene/25252).
In an attempt to focus the search, we noted that there is
86% sequence homology between the PDZ3 domain of
SAP97 and the PDZ3 domain of PSD95 (Fig. 1A). Since
CRIPT binds to the PDZ3 domain of PSD95 (Niethammer
et al., 1998), we tested CRIPT binding to the PDZ3 domain
of SAP97. We used a heterologous expression system in
HEK293 cells and established that FL HA-tagged CRIPT
(HA-CRIPT) and FL myc-tagged SAP97 (myc-SAP97) co-
immunoprecipitated (Fig. 1B). Anti-HA IgG, but not a con-
trol IgG, successfully coimmunoprecipitates HA-CRIPT
and myc-SAP97. To determine whether the PDZ3 domain
of SAP97 mediates this interaction, we attempted to co-
immunoprecipitate HA-CRIPT with versions of FL SAP97
containing ligand binding-disabling mutations in either the
PDZ2 (K323A, K326A) or PDZ3 (H469A, R470A) domain.
We found that mutations in the PDZ3 domain, but not in
the PDZ2 domain, completely abolished binding of CRIPT
to SAP97 (Fig. 1C). Next, we attempted to coimmunopre-
cipitate FL myc-SAP97 with two versions of CRIPT: (1) a
WT FL CRIPT and (2) a version of FL CRIPT harboring a
point mutation in the C-terminal valine (the PDZ3-binding
motif of CRIPT, -QTSV). This mutation was previously
shown to disrupt the binding of CRIPT to PSD95 (referred
to as CRIPT V101A), but not CRIPT’s binding to microtu-
bules (Passafaro et al., 1999). We found that the V101A
mutation prevented CRIPT’s binding to SAP97 (Fig. 1D).
As a specificity control, we asked whether another SAP97-
binding partner, APC, also showed differential binding. In
contrast to CRIPT, APC was pulled down equivalently by WT
SAP97 and PDZ3 mutant SAP97 (Fig. 1E). Taken together,
these data suggest that CRIPT specifically interacts with the
third PDZ domain of SAP97, and this interaction relies on the
canonical PDZ-interaction motif of CRIPT at its C terminus.
We complemented these observations with two further
approaches. First, in a Y2H assay, we found that FL
CRIPT interacts with the PDZ3 domain of SAP97. FL
CRIPT neither interacted with an empty bait vector, nor
did the SAP97 PDZ3 domain interact with an empty prey
vector (Fig. 1F). Second, SPR studies were performed
with immobilized GST-PDZ3 or GST and peptides corre-
sponding to the C-terminal 18 amino acids of CRIPT. We
found that WT CRIPT peptide bound to the PDZ3 domain
of SAP97 with a Kd of 6.57 M, while V101A mutant
showed no saturable binding to the PDZ3 domain of
SAP97 (Fig. 1G). Prior work suggests that ligand binding
to PDZ domains can vary substantially as a function of: (1)
method (i.e., SPR or fluorescence polarization; Hung and
Sheng, 2002) and (2) the length, in amino acids, of the
peptide ligand (i.e., longer peptides displaying lower Kd).
Niethammer et al. (1998) showed that a peptide corre-
sponding to the C-terminal nine amino acids of CRIPT
binds to the PSD95 PDZ3 with a Kd 	 1 M. These
results cannot be directly compared with our observa-
tions, because Niethammer et al. (1998) used fluores-
cence polarization as opposed to SPR. Nonetheless, our
observations are within the range of reported affinities for
ligand binding to isolated PDZ3 (Irie et al., 1997) and as
such are consistent with a direct interaction between the
PDZ3 domain of SAP97 and the C terminus of CRIPT.
To study a more physiologic setting, we asked whether
CRIPT and SAP97 coimmunoprecipitated using lysates
prepared from mixed spinal cord cultures. Anti-CRIPT
antibody, but not a control IgG, was able to immunopre-
cipitate CRIPT and SAP97 together (Fig. 1H). Immunore-
activity at 50 and 25 kDa in the “input” lane may
represent a minor amount of spill over from the adjacent
“control IgG” lane. As expected, prominent immunoglob-
ulin heavy and light chain bands are present in the immu-
noprecipitated material, as seen in the control IgG and the
anti-CRIPT IgG lanes. This experiment confirms that en-
dogenous CRIPT and SAP97 physically interact within a
nervous system setting.
The above described biochemical studies make the
case for a direct physical interaction between CRIPT and
PDZ3 of SAP97. However, all biochemical studies come
with caveats, and it remains possible that the interaction
between CRIPT and PDZ3 of SAP97 (Fig. 1B–H) is indi-
rect. To gain further insight into this potential binding, we
attempted to model this interaction at the atomic level.
We began by refining the deposited PSD95 PDZ3/CRIPT
interaction and then modeled the SAP97 PDZ3/CRIPT
complex based on the refined PSD-interacting features
(Fig. 2). The main residues directly involved in CRIPT
binding to PDZ3 of PSD95 and SAP97 are conserved (Fig.
1A, yellow). The C-terminal three residues of CRIPT that
bind to PDZ3 of PSD95 and SAP97 are identical. In the
PSD95/CRIPT structure, the side chains of D332 in
PSD95 and K(-4) in CRIPT are not defined in the original
crystal structure. In our modeled structure, K(-4) of CRIPT
forms a salt-bridge with D332 of SAP97 PDZ3. Addition-
ally, K(-7) of CRIPT forms a pair of salt-bridges with D485
and E487 from the beta strand B/alpha helix C (B/C-
loop) of SAP97 PDZ3. Finally, Y(-5) of CRIPT interacts
with the hydrophobic residues in the C-terminal -helix
extension of SAP97. These additional charge-charge, hy-
drogen bonding, and hydrophobic interactions between
the N-terminal sequences of the CRIPT peptide and the
B/C-loop of PDZ3, in addition to the canonical PDZ-
binding motif and PDZ3 interactions, could enhance both
the binding affinity and specificity between SAP97 and
CRIPT. This new in silico analysis provides a plausible
physical means by which CRIPT could directly interact
with SAP97.
Previous localization work (at the light and electron
microscopic levels) places CRIPT in the PSD 35 nm
from the inner leaflet of the plasma membrane and hip-
pocampal cultures, CRIPT colocalizes with PSD95 at ex-
citatory synapses (Niethammer et al., 1998). In light of the
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known physical interaction between GluA1 and SAP97
(Sans et al., 2001; Zhou et al., 2008; Zhang et al., 2015),
we explored the localization of these proteins and their
relationship to synapses using immunocytochemical tools
in mixed spinal cord cultures. The antisera generated to
CRIPT by the Sheng lab (Niethammer et al., 1998) is no
longer available and despite investigating a variety of
fixation protocols, we found that none of the commercially
Figure 1. CRIPT is bona fide PDZ3 and SAP97 interacting protein. A, Amino acid sequence alignment of the PDZ3 domains of human
SAP97 and human PSD95; there is 86% identity. Residues highlighted in yellow indicate amino acids directly involved in binding the
C terminus of CRIPT. Arrows and cylinders above the amino acid sequence indicate secondary structure of the PDZ domain (i.e., A
means beta strand A, A means alpha helix A, etc.). B, FL myc-tagged SAP97 coimmunoprecipitates with FL HA-tagged CRIPT using
the anti-HA antibody when they are overexpressed in HEK293 cells. Neither protein immunoprecipitates with a negative control IgG.
C, Overexpressed HA-tagged CRIPT coimmunoprecipitates with myc-tagged SAP97 containing a mutation in the PDZ2 domain
(K323A, K326A), but mutation of the PDZ3 domain (H469A, R470A) disrupts this interaction. D, Overexpression of myc-tagged FL
SAP97 and FL WT CRIPT or FL CRIPT V101A in HEK293 cells and immunoprecipitation SAP97 using myc IgG. Mutating the
PDZ3-interaction motif of CRIPT (CRIPT V101A) abolishes the interaction between SAP97 and CRIPT. E, anti-SAP97 (but not a control
IgG) immunoprecipitates WT or PDZ3 mutant version of SAP97 equivalently from cell lysates, as revealed by assay for supernatant
after IP. FL SAP97 interacts with FL APC protein in HEK293 cells, but this interaction does not rely on a ligand-binding PDZ3 domain
in SAP97. F, FL CRIPT interacts with the PDZ3 domain of SAP97 in a Y2H assay. G, SPR shows a specific and saturable interaction
between the 18 C-terminal amino acids of CRIPT and the PDZ3 domain of SAP97 (Kd of 6.57 M), but no interaction when the CRIPT
V101A mutation is present. Values shown were subtracted by a negative control GST peptide. H, Endogenous CRIPT and
endogenous SAP97 coimmunoprecipitate in lysates prepared from DIV14 mixed spinal cultures. Immunoblotting of endogenous
SAP97 and CRIPT proteins in input lysate and immunoprecipitations using a negative control IgG and CRIPT IgG. Blot was incubated
with SAP97 and CRIPT antibody simultaneously.
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available antibodies to CRIPT were suitable for immuno-
cytochemical imaging of endogenous CRIPT. To over-
come this difficulty, we knocked down endogenous
CRIPT and coexpressed an RNAi resistant HA-tagged
CRIPT (see Materials and Methods). CRIPT immunoreac-
tivity was seen in the cell soma and throughout the
dendritic tree (Figs. 3, 4), as previously reported by Niet-
hammer et al. (1998); axons appear devoid of CRIPT
immunoreactivity. This pattern of immunoreactivity is very
similar to that described by Niethammer et al. (1998; Fig.
5B,E,G).
Niethammer et al. (1998) describe CRIPT localization to
synapses on dendritic spines. In our spinal cord neuron
cultures we do not typically see dendritic spines (Zhang
Figure 2. Structural model of SAP97 PDZ3 in complex with the CRIPT C-terminal tail. A, The SAP97 PDZ3/CRIPT peptide complex
structure modeled using the experimentally derived PSD95 PDZ3/CRIPT complex structure (PDB id:1BE9) depicted in B. In these
drawings, the CRIPT peptide is depicted in purple.
Figure 3. CRIPT partially colocalizes synaptophysin containing synapses. Mixed spinal cord cultures at DIV21 were immunocyto-
chemically analyzed. The first row of panels shows immunocytochemical staining for HA-CRIPT (red), synaptophysin (green), and both
together in the merge image. HA-CRIPT immunoreactivity is seen within the soma and throughout the dendritic tree. This localization
data matches what was previously reported (Niethammer et al., 1998b). Scale bar: 20 m. Beneath each of the lower power images
are higher magnification images of the area outlined in a white box. In the high-power HA-CRIPT panel, immunocytochemically
positive material is seen in various morphologies within the dendritic tree including small or large round puncta and elongated
dendritic shaft entities. HA-CRIPT appears inhomogenously within dendritic outgrowths that may represent spines or filopodia. In the
merge image, areas of overlap (HA-CRIPT synaptophysin) are yellow and are highlighted with. Scale bar: 5.0 m. These are likely
to represent synapses.
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et al., 2015), yet we find that CRIPT is juxtaposed to (and
partially overlaps with) synaptophysin puncta on the
shafts of dendrites (Fig. 3). Niethammer et al. (1998) de-
scribe the localization of CRIPT with PSD95, and we too
find that CRIPT is juxtaposed to (and partially overlaps
with) SAP97 as well as GluA1 (Fig. 4).
It is important to note, however that the focal accumu-
lations of CRIPT that we describe here (Figs. 3, 4) and
their partial colocalization with SAP97 and GluA exist
within a background of diffuse CRIPT immunoreactivity
within dendrites. We cannot rule out the possibility that
some of the immunocytochemical signal is a result of the
Figure 4. CRIPT partially colocalizes GluA1-positive and SAP97-positive puncta on dendrites. Mixed spinal cord cultures at DIV21
were immunocytochemically analyzed. The upper set of panels display images of HA-CRIPT and EGFP-SAP97, and the lower set of
panels display images of HA-CRIPT and GluA1. For the HA-CRIPT/EGFP-SAP97 panels, the first row of panels shows immunocy-
tochemical staining for HA-CRIPT (red), EGFP-SAP97 (green), and merge. As in Figure 3, HA-CRIPT immunoreactivity is seen within
the soma and throughout the dendritic tree. EGFP-SAP97 is similarly distributed but appears more punctate. In the merge image,
extensive colocalization is seen (yellow) both in the soma and the dendritic tree. Scale bar: 30 m. Beneath each of the lower power
images are higher magnification images of the area outlined in a white box. In the high-power HA-CRIPT panel, immunocytochem-
ically positive material is again seen in various morphologies within the dendritic tree, including small or large round puncta and
elongated dendritic shaft entities. HA-CRIPT appears inhomogenously within dendritic outgrowths that may represent spines or
filopodia. EGFP-SAP97 is clearly more punctate than HA-CRIPT and in the merge image areas of colocalization are seen (yellow,
denoted with ). EGFP-SAP97 appears enriched at along the edges of HA-CRIPT immunoreactivity. Scale bar: 10 m. For the
HA-CRIPT/GluA1 panels, the first row of panels shows immunocytochemical staining for HA-CRIPT (red), GluA1 (green), and merge.
Again, HA-CRIPT immunoreactivity is seen within the soma and throughout the dendritic tree. GluA1 is seen exclusively as puncta.
In the merge image, colocalization is seen (yellow) in the dendritic tree. Scale bar: 20 m. Beneath each of the lower power images
are higher magnification images of the area outlined in a white box. In the high-power HA-CRIPT panel, immunocytochemically
positive material is again seen in various morphologies within the dendritic tree including small or large round puncta and elongated
dendritic shaft entities. HA-CRIPT appears inhomogenously within dendritic outgrowths that may represent spines or filopodia. GluA1
is exclusively punctate and in the merge image areas of colocalization are seen (yellow, denoted with ). GluA1, like EGFP-SAP97,
appears enriched at along the edges of HA-CRIPT immunoreactivity. Scale bar: 4.0 m.
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Figure 5. CRIPT is necessary, but not sufficient, for the dendritic growth of spinal cord neurons. Mixed spinal cord cultures were used
for biochemistry and morphometry. A, DIV14 cultures were infected with HSV engineered to express a miRNA that targets CRIPT or
a scrambled sequence control. Lysates were probed for CRIPT and the miRNA to CRIPT reduces the abundance of CRIPT by Western
blotting compared to a scrambled miRNA. B, Knockdown of CRIPT results in a significant decrease in a decrease in the number of
branches and total dendritic length of the dendritic tree. No other dendritic parameter was different between groups; differs from
GFP group, p  0.05; †differs from scrambled miRNA group, p  0.05. C, HEK 293 cells were transfected with plasmids
engineered to express miRNA targeted to CRIPT (or scrambled sequence control) and WT-CRIPT (CRIPTWT) or a miRNA-resistant
version of CRIPT (CRIPTres). When lysates were probed for CRIPT, we saw reduced abundance of CRIPTWT but not the CRIPTres by
the miRNA targeted to CRIPT. D, Cotransfection of RNAi-resistant CRIPT is sufficient to prevent decrease in the number of branches
and total length of the dendritic tree by CRIPT miRNA; differs from GFP group, p  0.05; †differs from CRIPT miRNA group, p
 0.05. CRIPT was modified with a sequence from paralemin-1 to allow for palmitoylation was generated. E, HEK293 cells were
transfected a plasmid engineered to express CRIPTWT or palmitoylated CRIPT, and cells were lysed and fractionated to enrich for the
cytosol or membrane fractions. Western blottings for CRIPT show that CRIPTWT is predominantly in the cytosolic fraction and
palmitoylated CRIPT is predominantly in the membrane fraction. F, Overexpression of WT CRIPT or pal-myc CRIPT has no effect on
the size or complexity of the dendritic tree compared with GFP only expressing neurons.
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knockdown and replacement strategy we employ and
thus only approximates the distribution of the native pro-
tein in situ. Given these caveats, our results suggest that
a portion of dendritic shaft CRIPT apparently localizes to
synapses along with components of AMPA-R complexes
such as GluA1 and SAP97. This would be consistent with
the immunogold electron microscopic localization studies
of Niethammer et al. (1998). The precise relationship be-
tween these complexes and those defined by Nietham-
mer et al. (1998; e.g., composed of GRIN2B, PSD95, and
CRIPT) will require further inquiry. Super-resolution mi-
croscopy, array tomography (Micheva et al., 2010), and
the proximity ligation in situ assay (Söderberg et al., 2006)
are imaging technologies particularly well suited for in-
quiry into the fundamental relationship between these
proteins.
CRIPT is necessary for proper dendrite growth
To identify the functions of CRIPT, we began by using
RNA interference (RNAi) to knockdown CRIPT in mixed
spinal cord cultures. We targeted a miRNA to the rat
ortholog of CRIPT, engineered it into a HSV amplicon
vector, and infected DIV14 mixed spinal cord cultures
with the virus and probed for CRIPT. We determined that
the CRIPT miRNA, but not a miRNA to a scrambled
sequence (control), effectively knocked down CRIPT in
neurons in vitro (Fig. 5A). Using this tool, we knocked
down CRIPT in spinal cord neurons and quantitatively
analyzed dendritic architecture. To do this, we compared
the dendritic tree of three experimental groups: (1) GFP
alone, (2) GFP  the scrambled miRNA, and (3) GFP 
active CRIPT miRNA by making camera lucida drawings
of the dendritic trees in each condition. To assess the
effect of CRIPT knockdown on dendritic morphology, we
characterized a number of architectural features as de-
scribed in Materials and Methods (Zhang et al., 2008;
Zhou et al., 2008; Zhang et al., 2015). Group differences
were found in branch number (Kruskal-Wallis H test,
H(2,73) 	 14.152, p 	 0.001) and total dendrite size
(ANOVA, F(2,73)	 6.893, p	 0.002). We found that knock-
down of CRIPT led to a 30% reduction in the number of
dendritic branch points compared to GFP alone (p 0.05)
or scrambled miRNA (p  0.01)-treated neurons (Fig. 5B).
In addition, we found that knockdown of CRIPT also led to
a 20% decrease in the total size of the dendritic tree
compared to GFP alone (p  0.0002) or the scrambled
miRNA (p  0.05). To confirm the effect of CRIPT knock-
down was in fact due to the reduced levels of CRIPT, we
created an RNAi-resistant CRIPT cDNA (CRIPTres) by in-
troducing silent mutations into the CRIPT miRNA target
sequence (see Materials and Methods). We confirmed
that CRIPTres was resistant to knockdown by the CRIPT
miRNA, compared to the WT version of CRIPT (CRIPTwt)
when expressed in HEK293 cells (Fig. 5C). With this tool at
our disposal, we compared the dendritic architecture of 3
experimental groups: (1) GFP  scrambled miRNA, (2)
GFP  CRIPT miRNA, and (3) GFP CRIPT miRNA 
CRIPTres. Group differences were seen in branch number
(H(2,73) 	 9.846, p 	 0.007) and total dendrite size (H(2,73)
	 9.364, p 	 0.009). CRIPT knockdown again reduced
the total number of branches (p  0.05), as well as the
total size (p  0.01), of the dendritic tree compared to the
scrambled miRNA (Fig. 5D). Rescuing CRIPT expression
in CRIPT knockdown neurons using the CRIPTres cDNA
completely reversed this effect. There was no difference
in any of the dendritic parameters tested compared to the
scrambled miRNA (Fig. 5D). These data suggest that
CRIPT is required for proper dendritic growth in vitro in
mammalian spinal cord neurons.
CRIPT is not sufficient to induce growth of the
dendritic tree
We next asked whether increasing CRIPT expression
influenced dendrite architecture. At the outset, we con-
sidered the possibility that only a limited number of
CRIPT-binding sites exist at the plasma membrane. This
would potentially mask a dendrite growth promoting phe-
notype of CRIPT overexpression. To test this idea, we
overexpressed two different versions of CRIPT in spinal
cord neurons: (1) WT CRIPT and (2) a version of CRIPT
that was palmitoylated at the N terminus of CRIPT to allow
CRIPT to traffic to the cell surface (pal-myc-CRIPT). The
palmitoylation sequence was derived from paralemmin-1
and placed on the N terminus of CRIPT. Subcellular frac-
tionation followed by Western blotting confirmed that
palmitoylated CRIPT (pal-myc-CRIPT) is found predomi-
nantly in the membrane fraction, whereas CRIPT without
the palmitoylation sequence is predominantly cytosolic in
this preparation (Fig. 5E). To determine whether overex-
pression of these CRIPT constructs influenced dendritic
architecture, we compared 3 groups: (1) GFP, (2) WT
CRIPT, and (3) pal-myc-CRIPT. By Kruskal-Wallis H
test, no group differences were found (Fig. 5F). Taken
together, these overexpression studies indicate that
CRIPT alone is not sufficient to promote dendrite growth
on its own, even when CRIPT is artificially targeted to the
plasma membrane to overcome any potential saturation
of CRIPT membrane-binding sites.
CRIPT is required for the dendrite growth promoting
activity of SAP97
Prior work has shown that SAP97 promotes dendritic
growth of motor neurons in vitro and in vivo (Zhang et al.,
2008; Zhou et al., 2008). We next asked whether CRIPT
was required for the dendritic growth promoting activity of
SAP97. To address this question, three groups of neurons
were studied: (1) GFP, (2) SAP97  scrambled
miRNA, and (3) SAP97  CRIPT miRNA. Group differ-
ences were seen in branch number (H(2,73) 	 8.212, p 	
0.016) and total dendrite size (H(2,73) 	 8.592, p 	 0.014)
. In the presence of the scrambled miRNA, overexpres-
sion of SAP97 led to a 30% increase in the total length
and 30% increase in branch number of the dendritic
tree compared to transfection with GFP alone (p  0.05;
Fig. 6) consistent with past findings (Zhang et al., 2008).
The promotion of dendritic growth by overexpression of
SAP97 was entirely blocked when CRIPT was knocked
down in the same group of neurons (Fig. 6). These obser-
vations suggest that CRIPT is required for the dendrite
growth-promoting actions of SAP97 and is part of the
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machinery required for SAP97-dependent developmental
phenotypes.
Loss of CRIPT influences the expression of select
components of excitatory synapses
Passafaro et al., reported that CRIPT influences post-
synaptic MAGUK clustering without affecting NMDA-Rs
or synaptophysin-labeled presynaptic elements (Passa-
faro et al., 1999). These observations and conclusions
were based on use of a cell-penetrating peptide (16 amino
acids of the antennapedia homeodomain) linked to the
C-terminal nine amino acids of CRIPT (“antp-CRIPT”).
While antp-CRIPT had the virtue of competing (and there-
fore blocking) the interaction all proteins that bind to the C
terminus of CRIPT, this reagent also acts as a dominant-
negative inhibitor of ligands for PDZ3 of all MAGUKs.
Thus, the specific role of CRIPT in synaptic molecular
biology is undefined. To begin to address this issue, we
knocked down CRIPT in spinal cord cultures using the
validated miRNA described above and prepared lysates
for Western blottings. We find that knockdown of CRIPT
led to a significant reduction in the abundance of GluA1
and SAP97, but had no effect on the abundance of GluA2,
GluA4, NR1, NR2A, NR2B, or PSD95 (Fig. 7). Thus, loss of
CRIPT leads to very specific changes in components of
AMPA-Rs and PSD MAGUKs. These observations are the
first clues suggesting that CRIPT can regulate excitatory
neurotransmission (through changes in heterooligomeric
assembly of AMPA-Rs) and downstream consequences
(through changes in the composition of the PSD). The use
of dynamic reporters of synaptic function, electrophysiol-
ogy and super-resolution microscopy will be required in
the future to precisely define the molecular mechanisms
of CRIPT action on synaptic biology.
CRIPT promotes dendritic growth in vivo
Our understanding of in vivo biology of CRIPT is ham-
pered by the fact that CRIPT null mice die at embryonic
day 9 and no conditional alleles exist. One potential path
forward is to study the in vivo effects of CRIPT in phylo-
genetically lower animals. CRIPT is an ancient gene and
was likely to exist in the last common ancestor before the
split of the Animalia and Plantae kingdoms of life. The C.
elegans genome contains a CRIPT ortholog (C36B1.14)
that is 38.8% identical to hCRIPT and both proteins are
very basic (pI hCRIPT is 9.57 and pI of C. elegans CRIPT
is 9.61). CRIPT message is expressed in embryonic
(Moore et al., 2005; Stetina Von et al., 2007), early larval
(Stetina Von et al., 2007), and adult (Kaletsky et al., 2016)
neurons (http://www.vanderbilt.edu/wormdoc/wormmap/
WormViz.html). The cardinal feature of hCRIPT is 8 cys-
teine residues and C. elegans CRIPT has seven cysteine
residues in register with their locations in the human
protein. A mutant allele of cript allele exists (tm430 con-
tains 400-bp deletions near the C-terminal region of the
protein, which would eliminate CRIPT’s PDZ-interaction
motif) and is likely to be a null. In light of these consider-
ations, we studied of the in vivo biology of CRIPT biology
in C. elegans.
We began by asking whether loss of CRIPT influences
the size and complexity of the dendritic tree of a single
neuron. To this end, we used a C. elegans reporter strain
with GFP expressed in the well-characterized PVD
mechanosensory neuron (Smith et al., 2010; Smith et al.,
2013). The PVD neuron dendrites showed an 25% de-
crease in the branches of secondary and tertiary dendrites
in the cript(tm430) background versus the WT (N2 Bristol
strain) background (p  0.05; Fig. 8A-D). We next asked
whether the dendrite growth defect of the cript mutant
was due to the loss of expression of CRIPT in neurons. To
study this, we expressed hCRIPT under the control of
a nervous system specific promoter (Punc-119::hCRIPT)
(‘Pneuron::hCRIPT’) in cript (tm430) mutants with GFP la-
beled PVD neurons. We found that neuronal expression of
hCRIPT was sufficient to rescue the decrease in second-
ary and tertiary branches in the cript (tm430) mutant to WT
levels (Fig. 8D). This effect was seen in three indepen-
dently generated transgenic lines (data not shown). Al-
though we have no direct evidence that CRIPT is
expressed at physiologically relevant levels in PVD neu-
rons, the fact that pan-neuronal expression of hCRIPT
rescues the abnormalities in the PVD neurons dendrites in
the cript(tm430) background, enables two observations:
(1) the loss of neuronal CRIPT is responsible for the
Figure 6. CRIPT functions downstream of SAP97 in promoting dendrite growth. Mixed spinal cord cultures were used for
morphometry. Knockdown of CRIPT prevents growth and branching caused by SAP97 overexpression in mixed spinal cord neurons;
differs from GFP group, p  0.05; †differs from SAP97  scrambled miRNA group, p  0.05.
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dendrite phenotype of PVD neurons in the cript(tm430)
animals, and (2) while parsimonious to infer that changes
in CRIPT within PVD neurons themselves account for
these observations, our results are equally consistent with
the idea that CRIPT has non cell-autonomous effects on
neuronal biology in the worm. In this later scenario, CRIPT
expression in non-PVD neurons might influence network
activity, for example, and thereby influence PVD neurons.
It is also worth remembering that PVD neurons are
sensory and the extent to which they are activated by
glutamate receptors (as with our studies of mammalian
neurons in vitro) is an open question. Regardless of these
specific details, our observations are the first in vivo dem-
onstration that CRIPT is essential for normal dendrite
elaboration and illustrate the remarkable evolutionary
conservation CRIPT function.
Loss of cript causes a mechanosensory defect in
vivo
We wondered whether the anatomic defects in PVD
neuron dendrites incurred by loss of cript had functional
consequences. C. elegans response to gentle stroking by
an eyelash is mediated by six neurons: ALML/R (where
“L” and “R” refer to the left and right side of the body),
PLML/R, AVM and PVM (Chalfie and Sulston, 1981). This
“light touch” response is lost in animals with mutation in
the amiloride-sensitive sodium channel encoded by the
mec-4 gene. However, animals with mutation in mec-4 do
respond to a stronger mechanical stimulus (e.g., touching
the midsection of the animal with a platinum wire) and this
response is lost when the PVD neuron is eliminated by
laser ablation (Way and Chalfie, 1989). The “harsh touch”
response is mediated by ALML/R, PLML/R, PVD, and
Figure 7. CRIPT knockdown leads to a selective reduction in the abundance of GluA1 and SAP97. Mixed spinal cord cultures were
infected with HSV engineered to express a miRNA targeting CRIPT or a scrambled control. Two days later, lysates were prepared and
subjected to Western blottings. No more than six independent experiments were performed for the quantitative image analysis. CRIPT
knockdown leads to a reduction in GluA1 and SAP97 abundance and no effect on the abundance of GluA2, GluA4, NR1, NR2A, NR2B,
or PSD95. Representative images of Western blottings with actin loading controls are shown and quantification of band intensity in
the bar graphs below; significant difference between groups, p  0.05.
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Figure 8. Loss of cript (tm430) decreases dendrite branch number in vivo and results in a mechanosensory defect; rescue with
hCRIPT. A, Representative full body image of PVD neuron labeled with GFP in the WT (N2 Bristol strain) young adult (L4 stage  1
d old). B, Schematic of PVD neuron and its primary (1˚), secondary (2˚), and tertiary (3˚) branches used for quantification. C,
Representative images of the PVD neuron labeled with GFP of indicated genotypes in the tail region used for quantification at the
young adult stage (L4 stage  1 d old). Gaps in the dendritic tree of cript (tm430) worms are noted with “v”. D, Quantification of the
number of primary (1˚), secondary (2˚), and tertiary (3˚) branches in indicated strains (n  10 per genotype). Analyst was blinded to
genotype during quantification. We found that cript (tm430) mutants have a significant decrease in secondary (p  0.01; post hoc
test following one-way ANOVA; F(3,37) 	 6.781; p 	 0.0009) and tertiary (p  0.01; post hoc test following one-way ANOVA; F(3,37)
	 6.365; p	 0.0014) branch number. This was completely rescued by overexpression of the human ortholog of CRIPT in the nervous
system using the unc-119 promoter (Pneuron), which also increased the number of primary dendrites compared to WT animals (p 
0.05); post hoc test following one-way ANOVA; F(3,37) 	 3.569; p 	 0.0232). E, WT, cript (tm430), mec-3 (e1338), and cript (tm430);
mec-4 (tu253) animals were scored for their response to touch. Average of three independent experiments is shown. Experiments
were all completed with analyst blinded to genotype. We found that cript (tm430); mec-4 (tu253) animals show a synthetic touch
defect (p 0.01 according to a post hoc test following a one-way ANOVA). We also confirmed that mec-3 (CB1338) animals are
touch defective compared to WT counterparts (p 0.005 according to a post hoc test following a one-way ANOVA; F(4,10)	 11.93;
p	 0.0008). F, Touch defect is suppressed in cript (tm430); mec-4 (tu253) animals by overexpression of the human ortholog of CRIPT
in the nervous system using the unc-119 promoter (Pneuron::hCRIPT) in four independent extrachromasomal array lines (p 0.01
according to a post hoc test following a one-way ANOVA when compared to nontransgenic counterparts). One strain (line 1) fully
rescued the touch defect when compared to WT in a post hoc test following a one-way ANOVA (F(8,18) 	 26.45; p  0.0001).
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perhaps the FLP sensory neurons. PVD function is typi-
cally assayed in a mec-4 mutant background as this
eliminates the light touch response and thus isolates
PVD-dependent behaviors (Liu and Shen, 2011). As a
positive control in touch assays, investigators use mec-
3(e1338) animals because they are insensitive to both
light and harsh touch (Way and Chalfie, 1989; Liu and
Shen, 2011). We took advantage of this simple yet pow-
erful system to inquire if the reduced branching of the
dendritic arbors of the PVD neuron seen in cript mutants
was associated with a functional deficit in the harsh touch
assay. We compared the response to harsh touch in five
C. elegans strains: (1) the WT N2 (a negative control), (2)
mec-3(e1338), (3) cript (tm430), (4) mec-4(u253), and (5)
cript (tm430); mec-4 (u253) double mutants (Fig. 8E). By
ANOVA, group differences were found (F(4,10) 	 11.93; p
	 0.0008). Using post hoc analysis, we confirmed that
40% of mec-3(e1338) mutant animals were defective to
harsh touch (p  0.05; they did not respond or move in
response to stimulus) in comparison to WT animals, in
which only 10% displayed a lack of response to harsh
touch. The cript (tm430);mec-4 (u253) double animals
displayed a significant (p  0.01) defect to harsh touch in
50% of animals compared to WT animals. There were
no significant differences between the single mutants [i.e.,
cript (tm430) or mec-4 (u253)] and N2 worms (Fig. 8E).
These observations indicate that the cript mutants are
incapable of compensating for the loss of mec-4. This
functional impairment could be due to the observed ab-
normality in dendrite growth of cript mutants.
Finally, we asked whether expression of hCRIPT in the
nervous system of cript mutant (tm430) worm would re-
store harsh touch sensitivity in the cript (tm430);mec-4
(u253) animals. We found that expression of hCRIPT in the
nervous system (Pneuron::hCRIPT) was sufficient to par-
tially rescue the harsh touch defect of the cript (tm430);
mec-4 (u253) animals. Approximately 55% percentage
of cript (tm430);mec-4 (u253) animals showed a harsh
touch defect and this was reduced to 25% when
hCRIPT was expressed in the nervous system (p  0.01).
This effect was found in 4 independently generated trans-
genic lines (Fig. 8F). These observations suggest that
neuronal CRIPT is required for normal touch responses in
mec-4(u253) mutant animals. Although pan neuronal ex-
pression of hCRIPT both rescues the PVD neuron den-
drite abnormality and touch sensitivity cript (tm430);
mec-4 (u253) animals, our data do not distinguish be-
tween a cell autonomous versus cell nonautonomous role
of CRIPT. It remains possible that CRIPT expression in
neurons, in addition to the touch critical neurons such as
PVD underlie, these observations.
Discussion
hSAP97 is a modular scaffolding protein that localizes
to the PSD and plays an essential role in translating the
activity of AMPA-R assembled with GluA1 into appropri-
ate dendrite growth and ensuring proper circuit patterning
(Zhang et al., 2008; 2015). We show here that CRIPT is a
bona fide binding partner of the prodendrite growth do-
main of SAP97, PDZ3. Our observations provide novel
insights into the currently limited knowledge about CRIPT
biology by showing that CRIPT is required for normal
dendrite growth both in vitro and in vivo. In addition, we
show that the loss of CRIPT in neurons causes behavioral
defects, highlighting the functional importance of CRIPT
in organizing neuronal circuits. The relevance of our re-
sults is suggested by the identification of children with
mutations in CRIPT. Two children with homozygous, likely
null, mutations are microcephalic and severely encepha-
lopathic (Shaheen et al., 2014); another child with a com-
pound heterozygous mutation is also microcephalic and
displays global developmental delay (Leduc et al., 2016)
Thus, while MAGUKs such as PSD95 and SAP97 can
substitute for each other in electrophysiological assays
(Schlüter et al., 2006; Howard et al., 2010), our data
indicate that CRIPT has a nonredundant and critical cell
biological function in neurons.
Many factors influence the computational work of neu-
rons including: (1) the size, geometry, and complexity of
the dendritic tree (Stuart et al., 1999); (2) the quantitative
and qualitative nature of the afferent input (Hume and
Purves, 1981; Inglis et al., 2002); (3) the molecular com-
position of synapses including which receptor-channels
reside in the synapse and their dynamic entry into and
egress from synapses; and (4) the molecular composition
of the PSD. The hundreds of proteins in the PSD are the
molecular actors that translate synaptic activity into last-
ing changes in synaptic function. Synaptic activity can
play a critical role in synaptic dynamics and one form of
activity-dependent development involves activation of the
NMDA subtype of glutamate receptor (Cline et al., 1987;
Kleinschmidt et al., 1987; Kalb, 1994). NMDA-R-mediated
dendrite growth and synaptic specification involves: (1)
elaboration of extracellular factors, such as BDNF, Wnts,
and nitric oxide (Wu et al., 1994; McAllister et al., 1995;
Cramer et al., 1996; Inglis et al., 1998; Ha and Redmond,
2008); (2) activation of intracellular signaling molecules
(Wu and Cline, 1998; Li et al., 2000; Li et al., 2002;
Redmond et al., 2002; Sin et al., 2002; Yu and Malenka,
2003; Gaudillière et al., 2004; Wayman et al., 2006; Ha
and Redmond, 2008; Peng et al., 2009); and (3) new gene
expression (Redmond et al., 2002; Gaudillière et al., 2004;
Shalizi et al., 2006; Li et al., 2009). CRIPT directly and
indirectly interacts with multiple components of the PSD
and is thus well positioned to modulate neuronal compu-
tations.
CRIPT interactome
Sequence analysis of CRIPT reveals domain architec-
tures such as zinc-fingers, tetratricopeptide-like helical
domains, JmjC domains, and aconitase/3-isopropylma-
late dehydratase, swivel domains (see InterPro, EMBL-
EBI). Protein interaction databases provide evidence for
CRIPT binding to all at least 11 proteins (see IntAct data-
base, EMBL-EBI). These in silico and unbiased large-
scale screening studies suggest that CRIPT interacts with
a wide variety of proteins and may be able to bind DNA
and/or double-stranded RNA. Our work shows that CRIPT
can be localized to synapses, as well as the cell body, of
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neurons, suggesting CRIPT has important functions in
several sites within the cell.
CRIPT binds PDZ3 of synaptic MAGUKs and this inter-
action is required for association of PSD95 with microtu-
bules (discussed further below; Passafaro et al., 1999).
Other biological actions of CRIPT, such as synaptic clus-
tering of MAGUKs (e.g., PSD95, PSD93 and GKAP; Pas-
safaro et al., 1999) and dendrite growth (Fig. 5) may also
depend on this interaction but this is not known. It is worth
noting that both C. elegans and D. melanogaster CRIPT
orthologues have a C-terminal threonine rather than valine
(as in mammals). While these two amino acids are steri-
cally similar, there are no known examples of a native PDZ
ligand ending in threonine. If exchanging threonine with
valine weakens the interaction of worm CRIPT with a PDZ
domain-containing protein, it suggests that the biological
actions of CRIPT on dendrites could be at least partially
independent of a CRIPT/PDZ domain interaction. Future
studies will be required to understand which protein-
protein interactions subserve CRIPT effects on neurons.
Prior work suggests that CRIPT binds microtubules
(causing them to bundle) and facilitates recruitment of
MAGUKs to bundled microtubules in a heterologous ex-
pression system (Niethammer et al., 1998; Passafaro
et al., 1999). Since the publication of these studies almost
20 years ago a more nuanced view of microtubule-binding
proteins has emerged and this raises questions about the
original observations regarding CRIPT and microtubules.
First, whether recombinant CRIPT directly binds purified
microtubules has not been demonstrated and so some of
the original observations may be due to indirect effects.
Second, some proteins that associate with the cytoskel-
eton, when overexpressed, can decorate microtubules
indiscriminately and reorganize with the cellular microtu-
bule network in nonphysiologic ways. How endogenous
CRIPT interacts with microtubules and controls their be-
havior is unclear. Third, immunogold electron microscopic
studies show that CRIPT concentrates in the PSD along
with MAGUKs (Niethammer et al., 1998), and this is con-
sistent with our own immunocytochemical localization
studies (Fig. 3). On the other hand, large stable microtu-
bules decorated with microtubule associated protein 2
reside in dendritic shafts and are absent from spines
(Landis and Reese, 1983; Matus, 2000; Kaech et al.,
2001). Even if endogenous CRIPT bound microtubules,
the extent to which this occurs at synapses is unknown.
We believe that while a stable MAGUK-CRIPT-micro-
tubule complex is unlikely to exist at synapses, these
observations do not exclude an ephemeral complex. Dy-
namic microtubules decorated with plus-end tracking
proteins actively explore spines (Gu et al., 2008; Hu et al.,
2008; Jaworski et al., 2009; Merriam et al., 2011; 2013). It
has been estimated that roughly 1% of spines contain
polymerized tubulin at any one time and that every spine
will have been invaded by microtubules every 24-h period
(Hu et al., 2008). If CRIPT is truly a microtubule-binding
protein, it could transiently link invading microtubules to
the PSD.
CRIPT cell biology
This work raises a number of issues for future investi-
gation. First, on the basis of the direct physical interaction
of CRIPT with SAP97 and other PSD MAGUKs, does
CRIPT influence MAGUK-mediated process such as: (1)
clustering and stabilizing glutamate receptors (Chen and
Featherstone, 2005; Elias et al., 2006; Waites et al., 2009),
(2) regulating spine size and density (Nikonenko et al.,
2008), and (3) trafficking of glutamate receptors to the cell
surface (Nicoll et al., 2006; Elias and Nicoll, 2007). Sec-
ond, several aspects of synaptic biology are influenced by
activity and whether CRIPT plays a role in these dynamic
processes is an open question. Third, dendritic distribu-
tion of CRIPT only partially overlaps with MAGUKs and it
is present at some but not all synapses. More advanced
imaging technologies may help inform us about the spa-
tiotemporal relationships between CRIPT, synapses, and
its myriad binding partners. Fourth, do familial mutations
in CRIPT impact dendritic and synaptic biology?
Understanding how activity-dependent development of
the dendritic tree is promoted may help develop tools that
can promote recovery following injury to the central ner-
vous system. For instance, repetitive activation of motor
circuits in experimental animals or humans has been
shown to improve rehabilitation in patients following mo-
tor injury (Dietz et al., 1995; Wernig et al., 1995; Edgerton
et al., 2001; Gazula et al., 2004; Ivey et al., 2008; Marchal-
Crespo and Reinkensmeyer, 2009; Lo et al., 2010). This is
consistent with our findings that activity promotes den-
dritic remodeling that in turn can promote development of
normal locomotor behavior (Inglis, et al., 2002; Zhang,
et al., 2008; Zhou, et al., 2008).
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